Rationale and Design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial
暂无分享,去创建一个
Carissa G. Fonseca | C. Albert | J. Finn | A. Kadish | D. Bello | R. Bonow | A. Schaechter | H. Subacius | J. Daubert | J. Goldberger
[1] W. Kannel,et al. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.
[2] R. Ideker,et al. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. , 1986, Circulation.
[3] H. Greene,et al. Sustained ventricular arrhythmias: differences between survivors of cardiac arrest and patients with recurrent sustained ventricular tachycardia. , 1988, Journal of the American College of Cardiology.
[4] J F Leclercq,et al. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.
[5] D. Spodick,et al. The incidence and prognosis of unrecognized myocardial infarction. , 1990, Archives of internal medicine.
[6] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[7] F. Venditti,et al. Classification of death in antiarrhythmia trials. , 1996, Journal of the American College of Cardiology.
[8] N Engl,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.
[9] A. Castellanos,et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.
[10] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[11] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[12] R. Kim,et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.
[13] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[14] R. Kim,et al. Visualization of presence, location, and transmural extent of healed Q-wave and non–Q-wave myocardial infarction , 2001 .
[15] O. Simonetti,et al. Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. , 2001, Radiology.
[16] Edwin Wu,et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.
[17] H. Huikuri,et al. Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.
[18] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[19] O. Simonetti,et al. TrueFISP: Assessment of accuracy for measurement of left ventricular mass in an animal model , 2002, Journal of magnetic resonance imaging : JMRI.
[20] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[21] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[22] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[23] Dipan J. Shah,et al. Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.
[24] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[25] Wolfgang G Rehwald,et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. , 2004, Journal of the American College of Cardiology.
[26] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[27] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[28] Peter Kellman,et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. , 2004, Journal of the American College of Cardiology.
[29] Kalyanam Shivkumar,et al. 253 CARDIAC MRI: INFARCT SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE , 2005, Journal of Investigative Medicine.
[30] Raja Muthupillai,et al. Quantitative assessment of left ventricular function: steady-state free precession MR imaging with or without sensitivity encoding. , 2005, Radiology.
[31] S. Sears,et al. Measuring Patient Acceptance of Implantable Cardiac Device Therapy: , 2005, Journal of cardiovascular electrophysiology.
[32] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[33] Raymond J Kim,et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. , 2005, Journal of the American College of Cardiology.
[34] R. Califf,et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. , 2005, American heart journal.
[35] Zengri J. Wang,et al. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.
[36] W. Stevenson,et al. Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.
[37] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[38] Emily A. Kuhl,et al. Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale , 2006, Pacing and clinical electrophysiology : PACE.
[39] Daniel C. Lee,et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study , 2007, Heart.
[40] Sebastian Kelle,et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. , 2007, The American journal of cardiology.
[41] Stephen L Moore,et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.